|
NEW PRODUCTS / PRODUCT NEWS
Intermittent, Sequential
Compression Therapy
|
The new VascuTherm 3 by ThermoTek offers
a combination of treatment modalities
that include intermittent pneumatic
compression for edema reduction, thermal
therapy (both cold and heat with alternating
contrast) for pain management, compression
for deep vein thrombosis prophylaxis,
and a special modality to enhance arterial
blood flow to treat arterial insufficiency.
The VascuTherm 3 delivers a proprietary
thermal compression therapy solution
in one easily transportable device.
Its solid-state technology eliminates
the need for ice and offers precise
temperature control combined with vascular
compression.
VascuTherm 3 Arterial Enhancement therapy
unit is used in conjunction with specially
designed therapy wraps to transfer pressure
to the foot and then the calf using
compressed air, to increase arterial
blood flow to the lower extremities.
It is designed to enhance blood flow
by providing targeted sequential compression
of the foot followed by the calf using
a rapid inflation/deflation pressure
pulse. The compression cycle initiates
with a quick compression of the popliteal
space of the foot to 120 mm Hg within
1 second, then a sequential compression
of the calf to 120 mm Hg within 2 seconds.
Following the compression phase, the
wraps are deflated rapidly and held
at rest for a period of 16 seconds.
The cycle is repeated 3 times per minute.
To
learn more, contact
ThermoTek,
Inc.
1200 Lakeside Parkway Ste 200
Flower Mound, TX 75028
www.thermotekusa.com
|
Preoperative Navigation
|
Wright Medical Group, Inc. has announced the full launch of its new PROPHECY™ Pre-Operative
Navigation Guides for knee arthroplasty.
The PROPHECY program enables surgeons to utilize basic computed tomography or
magnetic resonance imaging scan technology to plan precise implant placement
and alignment, before they enter the operating room. Wright Medical notes that,
in contrast to utilizing traditional instruments to align the knee during surgery,
the PROPHECY program utilizes computer imaging to develop patient-specific guides
that follow the unique curvature of the patient’s bone anatomy. The guides
produced by the PROPHECY program should fit snugly onto the end of bone by matching
the individual’s distinctive contour.
Once the procedure begins, patient-specific PROPHECY navigation guides allow
the surgeon to complete the implant placement with accuracy. By promoting accurate
alignment, providing optimal sizing, and guiding precision implant placement,
Wright’s new PROPHECY preoperative navigation delivers reproducible surgical
results for knee arthroplasty.
The PROPHECY™ Pre-Operative Navigation Guides are available in 2 options:
an Alignment and Resection Guide and a Pin Alignment Guide. For more information, contact
Wright Medical Technology, Inc.
5677 Airline Road
Arlington, TN 38002
phone 901-867-9971
fax 901-867-9534
www.wmt.com |
Innovative Knotless
Suture Anchor System
|
Core Essence Orthopaedics, Inc., a medical device company focused on soft-tissue
and skeletal repair of the extremities, announced it has received 510(k) regulatory
approval from the Food and Drug Administration for SECURUS™, a novel
knotless suture anchor system used in minimally invasive, arthroscopic surgery.
The company notes that SECURUS provides increased flexibility, simplicity,
and ease for surgeons seeking to employ minimally invasive techniques in the
surgical treatment of rotator cuff repair. The 510(k) regulatory approval means
Core Essence will be on track to ramp up distribution over the course of 2009.
SECURUS™ is an innovative implantable platform system that locks down sutures
in arthroscopic tendon repair surgeries, particularly high-volume shoulder procedures
focusing on rotator cuff repair. The product is available in 5.5-mm and 7.0-mm
diameters to address varying degrees of bone quality, as well as rescue potential.
The company notes that the SECURUS™ system also presents a number of distinct
benefits, including: consistent, reproducible bone and suture retention strength,
tactile tensioning of sutures (allowing the surgeon to “feel” the
tension in the soft tissue prior to locking the anchor), and a readily revisable
implant system. Unlike some knotless anchors, SECURUS™ can be adjusted
intraoperatively and even removed and replaced.
For more information, contact
Core Essence Orthopaedics, Inc.
301 Oxford Valley Rd., Suite 905B
Yardley, PA 19067-7702
phone (215) 310-9534
fax (215) 660-5014
www.ceortho.com |
Intramedullary
Fixation System
|
NovaLign™ Orthopaedics, Inc.,
received its first 510(k) clearance
from the US Food and Drug Administration
to market its Intramedullary Fixation
System, a new system of implants and
instruments for the treatment of long
bone fractures, including the humerus,
tibia, and femur.
Extensive preclinical testing in accordance
with internationally recognized testing
standards and applicable FDA guidances
support NovaLign’s 510(k) clearance.
The company plans to initiate clinical
studies in Europe and the United States
later this year.
In contrast to surgical approaches
in which intramedullary nails are inserted
through the nearest joint, the NovaLign
extracapsular intramedullary device
is designed to allow a surgeon to repair
a long bone fracture without violating
the nearby joint space, instead entering
the medullary canal from outside of
the joint. NovaLign’s goal is
to avoid damage to the surrounding
tissue, thereby minimizing the complications
that may be experienced with traditional
surgical techniques.
For more information, contact
NovaLign™ Orthopaedics,
Inc.
5885 Ridgeway Center Parkway, Suite 210
Memphis, TN 38120
phone 901-213-5151
www.novalign.com
|
Spinal
Bone Injury Treatment
| Osseon Therapeutics,
Inc., announced the commercial release
of their Osseoflex™ and Osseoperm™ systems
for the treatment of spinal bone injuries.
These products combine to form a new
procedure termed Osseoplasty™,
which allows for a minimally invasive
treatment of painful compression fractures
of the spine, seen increasingly in
older individuals with osteoporosis.
Thousands more develop compression
fractures as a result of trauma or
malignant disease such as breast cancer,
prostate cancer, and myeloma.
Osseoflex is a steerable and curvable
needle that can access the majority
of the vertebral body from a single
percutaneous access point. The company
notes that the Osseoperm system is
customized to deliver optimal cement
viscosity and precise cement placement
through the Osseoflex needle. Osseon
notes that, as a result, the Osseoplasty
procedure provides rapid stabilization
of vertebral fractures and significant
pain relief in most patients within
the same day. It plans to market
its Osseoplasty system throughout the
United States.
To learn more, contact
Osseon™ Therapeutics,
Inc.
2330 Circadian Way
Santa Rosa, CA 95407
phone (707) 636-5940
fax (707) 636-5941
www.osseon.com
|
|
